<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE342nnn/GSE342214/</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE342214</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>In vitro mechanisms of primary dermal fibroblast activation</name><description>Cancer-associated fibroblasts (CAFs) are the dominant stromal cell population in melanoma but remain poorly characterized due to a lack of validated in vitro models and subtype-specific markers. To address this, primary human dermal fibroblasts were activated toward an inflammatory-like CAF (iCAF) or myofibroblast-like CAF (myCAF) phenotype using four independent induction strategies: (1) treatment with lipopolysaccharide (LPS, iCAF-like) or TGF-beta (myCAF-like); (2) CRISPR-dCas9-mediated transcriptional activation of IL6 (iCAF-like) or ACTA2 (myCAF-like); (3) direct co-culture with unstimulated or LPS-stimulated peripheral blood mononuclear cells (PBMCs); and (4) culture in conditioned medium from SK-MEL-28 melanoma cells. Activation states were validated by RT-qPCR and Western blot for the canonical markers IL6 and ACTA2 prior to RNA sequencing (Illumina NovaSeq 6000, paired-end 150 bp). Bulk RNA-seq was performed on fibroblasts from each condition and matched controls to define the transcriptome-wide gene expression changes associated with iCAF- and myCAF-like activation, enabling derivation of subtype-specific gene signatures for downstream analysis of stromal reprogramming in melanocytic malignancy.</description><dates><publication>2026/09/01</publication></dates><accession>GSE342214</accession><cross_references><GSM>GSM9925780</GSM><GSM>GSM9925782</GSM><GSM>GSM9925781</GSM><GSM>GSM9925784</GSM><GSM>GSM9925783</GSM><GSM>GSM9925786</GSM><GSM>GSM9925785</GSM><GSM>GSM9925788</GSM><GSM>GSM9925787</GSM><GSM>GSM9925789</GSM><GSM>GSM9925771</GSM><GSM>GSM9925770</GSM><GSM>GSM9925773</GSM><GSM>GSM9925772</GSM><GSM>GSM9925815</GSM><GSM>GSM9925775</GSM><GSM>GSM9925774</GSM><GSM>GSM9925810</GSM><GSM>GSM9925777</GSM><GSM>GSM9925776</GSM><GSM>GSM9925812</GSM><GSM>GSM9925779</GSM><GSM>GSM9925778</GSM><GSM>GSM9925811</GSM><GSM>GSM9925814</GSM><GSM>GSM9925813</GSM><GSM>GSM9925762</GSM><GSM>GSM9925761</GSM><GSM>GSM9925805</GSM><GSM>GSM9925804</GSM><GSM>GSM9925807</GSM><GSM>GSM9925806</GSM><GSM>GSM9925809</GSM><GSM>GSM9925808</GSM><GSM>GSM9925764</GSM><GSM>GSM9925763</GSM><GSM>GSM9925766</GSM><GSM>GSM9925765</GSM><GSM>GSM9925801</GSM><GSM>GSM9925768</GSM><GSM>GSM9925767</GSM><GSM>GSM9925800</GSM><GSM>GSM9925803</GSM><GSM>GSM9925769</GSM><GSM>GSM9925802</GSM><GSM>GSM9925791</GSM><GSM>GSM9925790</GSM><GSM>GSM9925793</GSM><GSM>GSM9925792</GSM><GSM>GSM9925795</GSM><GSM>GSM9925794</GSM><GSM>GSM9925797</GSM><GSM>GSM9925796</GSM><GSM>GSM9925799</GSM><GSM>GSM9925798</GSM><GPL>24676</GPL><GSE>342214</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>